Bio-Intervention Specialists Announces a 37.5% Oversubscription for Its Third Round of Financing

Bio-Intervention Specialists Offers a 21st Century Disinfection Service that Utilizes a Revolutionary, Newly Registered EPA Disinfectant That is Category IV Practically Non-Toxic, Environmentally Friendly and Offers a Six Log Kill (99.9999%)

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Bio-Intervention Specialists (Bio-IS) announced today that on November 24, 2010, the Company closed a third round of financing that was oversubscribed by 37.5% and represents an increase in company valuation of 250%.

Since its first financing in December 2009, the EPA registration process for the state-of-the-art Electro-BioCide disinfectant utilized in its hospital disinfection services has been completed. Electro-BioCide is an EPA Category IV “practically non-toxic,” environmentally friendly, broad spectrum six log kill technology with a unique kill mechanism.

Tom Boyer, President and CEO, said: “We are very appreciative of our current and new shareholders for the faith they have demonstrated with these investments. We believe we have a unique solution for the challenge of infectious disease and are eager to deploy our service that can help save lives and reduce costs.”

Bio-IS’ hospital disinfection service focuses on improving the overall disinfection of a hospital’s physical plant through an integrated “Bio-Intervention Process.” Combining the unique power of Electro-BioCide with a state-of-the-art electrostatic spraying system and certified bio-intervention personnel, Bio-IS is prepared to quickly respond on-site to any hospital in the United States. Bio-IS provides hospitals with a 21st Century technology solution to replace the spray bottle and rag that have been used for hard-surface disinfection for decades. Bio-Intervention specialist personnel can respond to emergent situations or can be positioned permanently at any hospital. The company’s bio-intervention service solves the current weak links of hard-surface infection control.

Bio-Intervention Specialists is a dba of Aion Partners LLC and is privately held, owned by its founders and employees, physicians, senior executives in the healthcare sector, and other private investors. The founder and CEO is Tom Boyer, with almost 20 years of experience in the healthcare sector. He served on the Board of HCA/HealthONE LLC (the largest hospital company in Colorado), as Chairman of the Colorado Health Foundation, and was founding Chairman of the Colorado Center for Nursing Excellence.



CONTACT:

Media contact:
Lauri Harrison
303-885-4200
[email protected]
or
Company contact:
Tom Boyer – President and CEO
800-699-4230
[email protected]

KEYWORDS:   United States  North America  Colorado

INDUSTRY KEYWORDS:   Health  Hospitals  Infectious Diseases  General Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.